ZIOPHARM Oncology, Inc. (ZIOP) Posts Mixed Q1 Results

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reported Q1 EPS of ($0.32), $0.09 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $80 thousand.

For earnings history and earnings-related data on ZIOPHARM Oncology, Inc. (ZIOP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
• PSQ Holdings closes $1.3M private placement with board participation